Last update 21 Nov 2024

VGT-309

Overview

Basic Info

Drug Type
Fluorophore-conjugated therapeutics
Synonyms
fluorescent cathepsin-targeted imaging probe(Vergent Bioscience)
Mechanism
cysteine protease modulators(Cysteine protease modulators)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Boost your research with our ADC technology data.
Boost your research with our ADC technology data.

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Secondary malignant neoplasm of lungPhase 2
AU
05 Oct 2023
Secondary malignant neoplasm of lungPhase 2
US
05 Oct 2023
Lung CancerPhase 2
AU
11 Sep 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
40
(VGT-309 0.32mg/kg IV Given 12-36 Hours Prior to Surgery)
ugcmovylbi(pvngisnrhf) = jzmplvdyni iezdzgxnhh (kmxtvyvfyo, edqfyoohlw - tohqzlvwyu)
-
17 Oct 2024
(VGT-309 0.32mg/kg)
ylcaaskolf(yakdvlnlaz) = scrbrzbafs bjewxvruii (ufoknrukyj, phwkmjibul - nhshaizgzh)
Phase 2
40
lbzneitwhw(xjzxejlxxb) = hlzshqlzyw tajfvpwelz (pddkczasjr )
Met
Positive
18 Jul 2024
Phase 2
40
(lnktqhbrwa) = tjcmhhbokv aeoviipoev (jkuterdeai )
Positive
28 Jan 2024
WCLC2023
ManualManual
Phase 2
27
vreuqhjcrj(cehxjzhjps) = At 0.16mg/kg VGT-309, all cancerous lesions from participants dosed the day prior to surgery fluoresced both in situ and ex vivo, but none of the tumors from participants dosed on the same day had fluorescence in situ. At maximum dose of 0.32mg/kg at either interval, 12 of 15 confirmed cancers fluoresced, both in situ and ex vivo. ssrrvhheha (lywwibmcvs )
Positive
11 Sep 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free